Figure 6From: Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells Effect of Iripallidal on the viability of non-glioma cancer cell lines and normal human monocytes. (a) Viability of Iripallidal treated non-glioma cancer cell lines and (b) normal human monocytes were determined by MTS assay. Graph represents the percentage viable MCF-7 (breast), HeLa (cervical), HepG2 (hepatocellular carcinoma), THP1 (acute myeloid leukemia), HT-29 (colon carcinoma) cells and monocytes treated with 10 and 20 μM concentration of Iripallidal for 24 hours, as determined by MTS assay. C denotes control. * Significant decrease from control (P < 0.05).Back to article page